The goal of this proposal is to understand the regulation of EBV gene expression in immortalized B cells.
Two specific aims concern regulation of two promoters, Wp and Cp, that allow expression of the six EBNA genes, while a third aim concerns alternative splicing of the Wp- and Cp-initiated transcripts. The proposed studies also extend to a murine herpesvirus, gamma HV68.
Four specific aims are: (1) To investigate initiation of EBNA gene transcription upon infection of peripheral B cells by determining whether multiple W promoters are active during early stages of infection, whether the first one or two W promoters are required for establishment of latency, to map and characterize the cis and trans elements that are required for initial Wp activity. (2) To study regulation of EBNA gene expression in low-passage EBV-immortalized cells by characterizing LCL's that have been immortalized with viruses containing mutations in cis elements that are suspected to be involved in regulating C and W promoters; by characterizing Cp regulation in newly established LCLs that exhibit significant Wp activity; and by assessing the role of the Notch signaling pathway in maintenance of B-cell immortalization. (3) To investigate processing of long primary EBNA gene transcripts in EBV immortalized B cells. (4) To identify the cis- and trans-acting elements which are required for maintenance of latently infecting genomes of gamma herpesvirus 68.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA043143-15
Application #
6172536
Study Section
Special Emphasis Panel (ZRG5-EVR (02))
Program Officer
Wong, May
Project Start
1986-07-01
Project End
2001-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
15
Fiscal Year
2000
Total Cost
$264,027
Indirect Cost
Name
Washington University
Department
Pathology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Siegel, Andrea M; Rangaswamy, Udaya Shankari; Napier, Ruth J et al. (2010) Blimp-1-dependent plasma cell differentiation is required for efficient maintenance of murine gammaherpesvirus latency and antiviral antibody responses. J Virol 84:674-85
Krug, Laurie T; Collins, Christopher M; Gargano, Lisa M et al. (2009) NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency. J Virol 83:4732-48
Herskowitz, Jeremy H; Siegel, Andrea M; Jacoby, Meagan A et al. (2008) Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection. J Virol 82:3295-310
Siegel, Andrea M; Herskowitz, Jeremy H; Speck, Samuel H (2008) The MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiation. PLoS Pathog 4:e1000039
Krug, Laurie T; Moser, Janice M; Dickerson, Shelley M et al. (2007) Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency. PLoS Pathog 3:e11
Allen 3rd, Robert D; Dickerson, Shelley; Speck, Samuel H (2006) Identification of spliced gammaherpesvirus 68 LANA and v-cyclin transcripts and analysis of their expression in vivo during latent infection. J Virol 80:2055-62
Evans, Andrew G; Moorman, Nathaniel J; Willer, David O et al. (2006) The M4 gene of gammaHV68 encodes a secreted glycoprotein and is required for the efficient establishment of splenic latency. Virology 344:520-31
Herskowitz, Jeremy; Jacoby, Meagan A; Speck, Samuel H (2005) The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells. J Virol 79:2261-73
Willer, David O; Speck, Samuel H (2005) Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40. J Virol 79:2891-9
Moser, Janice M; Upton, Jason W; Allen 3rd, Robert D et al. (2005) Role of B-cell proliferation in the establishment of gammaherpesvirus latency. J Virol 79:9480-91

Showing the most recent 10 out of 63 publications